Key Finding
Lower baseline systemic immune-inflammation index, combined with lower BMI and higher lymphocyte count, independently predicted successful response to acupuncture and exercise therapy in knee osteoarthritis patients with moderate discriminative ability (AUC=0.858).
Researchers in China investigated whether a blood test measuring inflammation levels could predict who would benefit most from acupuncture and exercise therapy for knee osteoarthritis. The study examined 151 patients with moderate knee arthritis who completed an 8-week program combining acupuncture with rehabilitation exercises. Scientists measured a marker called the systemic immune-inflammation index (SII) from routine blood tests taken before treatment began. They found that patients with lower inflammation levels, lower body weight, and higher lymphocyte counts were more likely to experience meaningful improvements in pain and function. About half the patients (73 of 151) achieved significant clinical improvement, defined as at least a 2-point reduction in pain scores and a 6-point improvement in knee function. When used alone, the SII showed moderate ability to predict treatment success. However, combining the inflammation marker with body mass index and lymphocyte count improved prediction accuracy. The findings suggest that simple blood tests might eventually help identify which knee osteoarthritis patients are most likely to respond well to acupuncture and exercise therapy. This could allow practitioners to personalize treatment approaches and set realistic expectations. The study had limitations including its retrospective design and single treatment center, so larger studies are needed to confirm these results. If you're considering acupuncture for knee osteoarthritis, seek care from a licensed acupuncturist with experience treating musculoskeletal conditions.
This retrospective study (n=151) evaluated whether baseline systemic immune-inflammation index (SII) predicts response to combined acupuncture and exercise rehabilitation in Kellgren-Lawrence Grade II-III knee osteoarthritis. Treatment response was defined as achieving MCII thresholds (≥2-point NRS reduction and ≥6-point WOMAC function improvement) after 8 weeks. Response rate was 48.3% (73/151). Multivariate logistic regression identified three independent predictors: lower BMI (OR=0.596), higher lymphocyte count (OR=34.597), and lower SII (OR=0.912). ROC analysis revealed moderate discriminative ability for SII alone (AUC=0.749, 95% CI: 0.670-0.828), improving to AUC=0.858 when combined with BMI and lymphocyte count. Clinical takeaway: While SII shows promise as an accessible biomarker for treatment stratification, its moderate predictive power suggests it should be combined with other clinical parameters. Single-center retrospective design and absence of longitudinal SII measurements limit generalizability; prospective validation studies are needed.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Patients with AG/GG genotypes at GABRB3 rs4906902 demonstrated significantly superior analgesic responses to acupuncture treatment for knee osteoarthritis compared to AA carriers, associated with reduced striatal gray matter volume and elevated GABRB3 expression.
📌 Singapore developed seven evidence-based recommendations for knee osteoarthritis management using GRADE methodology with patient partnership, addressing gaps in conservative treatment uptake and providing guidance on appropriate use of complementary therapies.
📌 Isopsoralen alleviated osteoarthritis through dual mechanisms of MAPK/NF-κB pathway inhibition and gut microbiota modulation, with fecal transplantation experiments confirming that changes in gut bacteria were essential for therapeutic efficacy.